Patent details
EP2675450 Title: COMBINATIONS OF THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
Basic Information
- Publication number:
- EP2675450
- PCT Application Number:
- PCT/IB/2012/050669
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP127054575
- PCT Publication Number:
- WO/2012/110953
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATIONS OF THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
- French Title of Invention:
- COMBINAISONS D'AGENTS THÉRAPEUTIQUES POUR UNE UTILISATION DANS LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
- German Title of Invention:
- KOMBINATIONEN AUS THERAPEUTISCHEN WIRKSTOFFEN ZUR VERWENDUNG BEI DER BEHANDLUNG NEURODEGENERATIVER ERKRANKUNGEN
- SPC Number:
Dates
- Filing date:
- 14/02/2012
- Grant date:
- 10/02/2016
- EP Publication Date:
- 10/02/2016
- PCT Publication Date:
- 23/08/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/12/2013
- EP B1 Publication Date:
- 10/02/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/02/2016
- Expiration date:
- 14/02/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/02/2012
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- GALIMBERTI Ivan
- Address:
- Switzerland (CH)
2
- Name:
- MURPHY Leon
- Address:
- United States (US)
Priority
- Priority Number:
- 201161443493
- Priority Date:
- 16/02/2011
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/436;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|